AbbVie
ABBV
#26
Rank
A$752.98 B
Marketcap
A$425.99
Share price
-0.86%
Change (1 day)
18.70%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): A$8.50

According to AbbVie's latest financial reports the company's current EPS (TTM) is A$8.79. In 2025 the company made an earnings per share (EPS) of A$3.56 a decrease over its 2024 EPS that were of A$3.64.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$8.50138.87%
2025A$3.56-2.26%
2024A$3.64-11.86%
2023A$4.13-58.95%
2022A$10.062.49%
2021A$9.81121.58%
2020A$4.43-44.7%
2019A$8.0145.84%
2018A$5.499.72%
2017A$5.00-9.54%
2016A$5.5316.28%
2015A$4.76184.1%
2014A$1.67-57.15%
2013A$3.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.41 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.11 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.55-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.66-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.79-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.70 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$4.32-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$10.47 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA